# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123296
Filing Date
2024-11-07
Accepted
2024-11-07 16:06:56
Documents
114
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mnkd-20240930.htm iXBRL | 10-Q | 3407023
2 | EX-10.1 | mnkd-ex10_1.htm | EX-10.1 | 66271
3 | EX-10.2 | mnkd-ex10_2.htm | EX-10.2 | 13750
4 | EX-10.3 | mnkd-ex10_3.htm | EX-10.3 | 121172
5 | EX-31.1 | mnkd-ex31_1.htm | EX-31.1 | 14428
6 | EX-31.2 | mnkd-ex31_2.htm | EX-31.2 | 14427
7 | EX-32.1 | mnkd-ex32_1.htm | EX-32.1 | 9886
8 | EX-32.2 | mnkd-ex32_2.htm | EX-32.2 | 9898
| Complete submission text file | 0000950170-24-123296.txt |  | 16208986

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | mnkd-20240930.xsd | EX-101.SCH | 2513154
117 | EXTRACTED XBRL INSTANCE DOCUMENT | mnkd-20240930_htm.xml | XML | 2978652

Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 241435591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)